Role of drug sensitivity test in the triple therapy for eradication of Helicobacter pylori

Chinese Journal of Gastroenterology

Volumn 15, Issue 6, 2010, Pages 358-360

  Zhou, Jiahua ^a   Huo, Huifeng ^a   Wu, Ming ^a   Jiang, Xiaoqu ^a  

^a Shanghai Seamen's Hospital   (China)

Author keywords

Drug resistance; Helicobacter pylori; Microbial sensitivity tests

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ENDOSCOPIC BIOPSY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MICROBIAL SENSITIVITY TEST; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; TREATMENT RESPONSE; UREA BREATH TEST;

EID: 77956270233     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2010.06.011     Document Type: Article

References (11)

1. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology, 1998, 115 (5): 1272-1277. (Pubitemid 28485620)
2. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother, 1999, 43 (4): 511-515.
3. Dore MP, Leandro G, Realdi G, et al. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci, 2000, 45 (1): 68-76.
4. Pendland SL, Piscitelli SC, Schreckenberger PC, et al. In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. Antimicrob Agents Chemother, 1994, 38 (9): 2106-2110.
5. de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ, 2000, 320 (7226): 31-34.
6. Perri F, Festa V, Clemente R, et al. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther, 2000, 14 (3): 311-316.